INNOVATE Corp. grants restricted stock to CFO

Sena Michael J. reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Sena Michael J. reported acquisition or exercise transactions in this Form 4 filing.

INNOVATE Corp. reported that CFO and Corporate Secretary Michael J. Sena received a grant of 15,576 shares of restricted common stock on August 11, 2026. The award was granted at $0.00 per share under the company’s Second Amended and Restated 2014 Omnibus Equity Award Plan. These shares will vest in three equal installments on the first, second, and third anniversaries of the grant date, contingent on his continued employment on each vesting date. Following this award, Sena directly holds 131,558 shares of INNOVATE Corp. common stock.

Insider Trade Summary

Grant/Award: 15,576 shares

Grant/Award 1 txn

Insider Sena Michael J.

Role CFO and Corporate Secretary

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	15,576	$0.00	$0.00

Holdings After Transaction: Common Stock — 131,558 shares (Direct)

Footnotes (1)

1. F1. Reflects shares of restricted stock granted pursuant to the INNOVATE Corp. Second Amended and Restated 2014 Omnibus Equity Award Plan, as amended (the "Plan"). Shares will vest and become exercisable in three installments of one-third each on the first, second and third anniversaries of the Date of Grant (each a "Vesting Date"), subject to the continued employment of the Reporting Person on the applicable Vesting Date.

Key Figures

Restricted shares granted: 15,576 shares Grant price per share: $0.00 per share Shares after transaction: 131,558 shares +1 more

4 metrics

Restricted shares granted 15,576 shares Restricted common stock granted to CFO on August 11, 2026

Grant price per share $0.00 per share Equity award issued as compensation, not a market purchase

Shares after transaction 131,558 shares Total direct common stock holdings of Michael J. Sena after grant

Vesting schedule installments 3 installments Vesting in three equal parts on successive anniversaries of grant date

Key Terms

restricted stock, Omnibus Equity Award Plan, vesting

3 terms

restricted stock financial

"Reflects shares of restricted stock granted pursuant to the INNOVATE Corp."

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

Omnibus Equity Award Plan financial

"pursuant to the INNOVATE Corp. Second Amended and Restated 2014 Omnibus Equity Award Plan"

vesting financial

"Shares will vest and become exercisable in three installments of one-third each"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction did INNOVATE Corp. (VATE) report for Michael J. Sena?

INNOVATE Corp. reported that CFO Michael J. Sena received a grant of 15,576 shares of restricted common stock on August 11, 2026. The award was issued at $0.00 per share as part of his equity compensation package.

How many INNOVATE Corp. (VATE) shares does Michael J. Sena own after this grant?

After this restricted stock grant, Michael J. Sena directly holds 131,558 shares of INNOVATE Corp. common stock. This total includes the newly granted 15,576 restricted shares subject to future vesting conditions.

How do the restricted shares granted to INNOVATE Corp. (VATE) CFO vest?

The 15,576 restricted shares granted to the CFO vest in three equal installments on the first, second, and third anniversaries of the grant date. Vesting is conditioned on his continued employment on each vesting date.

Was the INNOVATE Corp. (VATE) Form 4 grant to the CFO a market purchase?

No, the reported transaction is a grant of restricted stock, coded as an acquisition (A), not an open-market purchase. The per-share price is $0.00, consistent with equity compensation awards.

Under what plan was the INNOVATE Corp. (VATE) restricted stock granted?

The 15,576 restricted shares were granted under the INNOVATE Corp. Second Amended and Restated 2014 Omnibus Equity Award Plan, which governs equity-based compensation awards to eligible participants.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/13/2026 - 04:13 PM Accepted by SEC EDGAR 08/13/2026 - 04:13 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Sena Michael J.

(Last) (First) (Middle)

C/O INNOVATE CORP.

295 MADISON AVENUE, 12TH FL

(Street)

NEW YORK NEW YORK 10017

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
INNOVATE Corp. [ VATE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO and Corporate Secretary

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/11/2026		A(1)		15,576	A	$0	131,558	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects shares of restricted stock granted pursuant to the INNOVATE Corp. Second Amended and Restated 2014 Omnibus Equity Award Plan, as amended (the "Plan"). Shares will vest and become exercisable in three installments of one-third each on the first, second and third anniversaries of the Date of Grant (each a "Vesting Date"), subject to the continued employment of the Reporting Person on the applicable Vesting Date.

Remarks:

	/s/ Michael J. Sena	08/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)